FdaApplication

NDA 021892

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSALIX PHARMACEUTICALS INC
application_typeNDA
approval_date2006-03-16

Products (1)

ProductActive ingredientStrengthDosage form
OSMOPREPSODIUM PHOSPHATE, DIBASIC, ANHYDROUS; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE0.398GM;1.102GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**TABLET;ORAL

1 product